Update shared on16 Oct 2025
Fair value Increased 5.88%Analysts have raised their price target for Bunge Global from $87.63 to $92.78. They cite substantially improved revenue growth expectations and updated financial metrics as key reasons for the change.
What's in the News
- Bunge Global issued earnings guidance for the second half of 2025, expecting EPS in the range of $4 to $4.25. The EPS ranges reflect different weighted average share counts for the full year and the half-year period. (Company guidance)
- Bunge Global was dropped from the FTSE All-World Index (USD). (Index update)
- As of June 30, 2025, Bunge Global has completed its share repurchase program announced in October 2021. The company bought back 19,667,739 shares, representing 13.56% of shares outstanding, for a total of $1,900.04 million. (Company buyback update)
Valuation Changes
- Fair Value increased from $87.63 to $92.78, reflecting a moderate upward revision.
- Discount Rate rose slightly from 6.40% to 6.78%.
- Revenue Growth increased significantly from 3.28% to 32.90%.
- Net Profit Margin decreased slightly from 2.01% to 1.89%.
- Future P/E declined from 15.77x to 12.24x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.